1. Home
  2. PBH vs IMNM Comparison

PBH vs IMNM Comparison

Compare PBH & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

N/A

Current Price

$62.00

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$21.00

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBH
IMNM
Founded
1996
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
PBH
IMNM
Price
$62.00
$21.00
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$80.75
$32.80
AVG Volume (30 Days)
358.7K
924.3K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
2.88
51.40
EPS
2.78
N/A
Revenue
$975,777,000.00
$6,941,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
$2.15
$863.23
P/E Ratio
$23.33
N/A
Revenue Growth
36.77
N/A
52 Week Low
$57.25
$5.15
52 Week High
$88.55
$27.65

Technical Indicators

Market Signals
Indicator
PBH
IMNM
Relative Strength Index (RSI) 30.65 42.40
Support Level $60.75 $18.98
Resistance Level $63.26 $22.57
Average True Range (ATR) 1.81 1.10
MACD -0.82 -0.09
Stochastic Oscillator 0.11 29.45

Price Performance

Historical Comparison
PBH
IMNM

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: